Resource Library for Healthcare Providers
SIJSS: Does the iFuse Procedure work? (Peter Whang, MD)
This presentation was recorded during the 4th SI Joint Surgery Society (SIJSS) Meeting 2014 - iFuse Surgeon User Group.
Peter Whang, MD* presents clinical study results of the iFuse Procedure.
Outline
- SI Joint Pathology – Burden of Disease
- Clinical Trials Overview – SIFI, INSITE, iMIA
- Clinical Evidence
*Peter Whang, MD is a paid consultant
and clinical trial investigator for SI-BONE, Inc.
The iFuse Implant System is intended for
sacroiliac fusion for conditions including sacroiliac joint dysfunction
that is a direct result of sacroiliac joint disruption and degenerative
sacroiliitis. This includes conditions whose symptoms began during
pregnancy or in the peripartum period and have persisted postpartum for
more than 6 months. There are potential risks associated with the iFuse
Implant System. It may not be appropriate for all patients and all
patients may not benefit. For information about the risks, visit: www.si-bone.com/risks